https://web.archive.org/web/20201024192513/https://www.webmd.com/lung/news/20201018/study-remdesivir-does-not-reduce-covid-mortality"
Study: Remdesivir Does Not Reduce COVID MortalityBy Ralph Ellis
650x350_IV
October 19, 2020 --
A large study sponsored by the World Health Organization found that remdesivir doesn’t help hospitalized patients with COVID-19 survive and doesn’t even shorten the recovery time of those who do survive.These findings contradict smaller studies which found remdesivir, an antiviral drug, helped hospitalized coronavirus patients recover faster than patients who received a placebo. Those earlier studies led the FDA to grant emergency use authorization for the drug, which has been given to thousands of COVID patients in the United States, including President Donald Trump.
The WHO-sponsored study was conducted from March 22 to Oct. 4 and involved 11,330 patients from 405 hospitals in 30 countries. Patients were given remdesivir and three other drugs singly or in combination.
“These remdesivir, hydroxychloroquine, lopinavir and interferon regimens appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay,” the study concluded.
The data was posted online in the preprint server medRxiv and has not been peer-reviewed or published in a scientific journal.
U.S. pharmaceutical company Gilead Sciences, the maker of remdesivir, issued a statement defending the drug, noting that controlled studies published in peer-reviewed journals validated its benefits.
Gilead also questioned how the study was conducted, saying there was variation in “trial adoption, implementation, controls and patient populations and consequently, it is unclear if any conclusive findings can be drawn from the study results.”
Dr. Peter Chin-Hong, MD, an infectious-disease expert at the University of California, San Francisco, told The New York Times that a massive study in different nations could result in inconsistent treatment methods.
“So much goes into care,” he said. “The drug is only part of it.”
Remdesivir was developed to treat Ebola and was repurposed to treat coronavirus.
It has been one of the few encouraging developments in the global battle against COVID-19."
Now there's a load, since even the earlier NIH study concluded Remdesivir was not shown to result in a "statistically significant reduction in mortality".
While most of the countries around the world use hydroxychloroquine and thereby average a 70+% lower death rate than countries like the U.S., Mexico, the U.K. and France whose citizens are deprived of HCQ.
https://www.covid-19forum.org/index.php?topic=244.0
As further evidenced by physicians that care enough about the welfare of their patients to practice (outside of what the NIH evilly dictated as "the standard of care"), like Dr. Brian Tyson's 100% success over 1900 patients with 0 deaths and only one hospitalized for four days. As well as Dr. Vladimir Zelenko's 99.75% success over 800 elderly and high risk patients. Along with hundreds more doctors around the U.S. that achieved similar results.
https://www.covid-19forum.org/index.php?board=3.0
As further reported ad nauseum by Yale School of Public Health professor of epidemiology Dr. Harvey Risch.
Folks need to stop using Google for information, that they don't want the truth censored out of, by a bunch of childish, clueless, deranged snowflakes that seem to believe they know better than board certified treating physicians."“It’s certainly disappointing,” Julie Fischer, an associate research professor in the Department of Microbiology and Immunology at Georgetown University, said of the study, according to Al Jazeera.
“What all of us would like to see is what is frequently called a ‘magic bullet’; a drug that’s already in existence, that is safe and works effectively in patients. Unfortunately, in this case, this trial at least suggests
the benefits of remdesivir weren’t there at all.”"
Which "magic bullet" is of course exactly what we have had ever since March, that is 99-100% effective even among elderly and high-risk patients in the early outpatient setting, that could have kept 90% or more of COVID patients from ever winding up in the hospital, if folks weren't being told to "go home and isolate" (in other words, for the elderly or high-risk, go home and die instead of receiving effective early treatment, but don't forget to stop by the hospital after you turn blue, and get your $3200 worth of Remdesivir on your way out!). These academics need to poke their heads up out of their bubbles now and then and look at what competent actual treating physicians have been doing since the beginning.
https://www.covid-19forum.org/index.php?board=3.0
[edit add 6-28-21] Then in April of 2020 another $20 multi-drug treatment protocol using the time-tested generic drug ivermectin, demonstrated tremendous efficacy not only in early treatment but as prophylaxis, as well as in all other stages of COVID since it possesses anti-inflammatory properties.
https://www.covid-19forum.org/index.php?topic=461.0 [end edit]"The FDA granted emergency use authorization to remdesivir in April, saying: "
While there is limited information known about the safety and effectiveness of using remdesivir to treat people in the hospital with COVID-19, the investigational drug was shown in a clinical trial to shorten the time to recovery in some patients.""
That is, shown in a bogus manipulated NIH study where the end point was altered. So they gave EUA to a risky new drug that damages the liver, kidneys and heart, that does not result in significantly lower mortality, while they revoked emergency use authorization for a safe 65-year old drug that is sold over the counter in many countries, that is taken by millions of Americans for Lupus and RA, day after day, year after year - in the same dosage that the Zelenko Protocol prescribes over just 7 days - that the AAPS declares is safer than aspirin, Tylenol or Benadryl, that has been shown to be up to 100% effective even in elderly and high-risk individuals in the early outpatient setting ever since March! Thereby placing doctors who are humane enough to prescribe it to be practicing outside the "standard of care" and therefore more subject to lawsuits, while having their licenses threatened by state and local bureaucrats for the crime of saving their patients lives."'A clinical trial of about 1,000 patients conducted by the National Institutes of Health found remdesivir shortened recovery time in about 31% of patients. The NIH also said the trial “suggested a survival benefit, with a mortality rate of 8.0% for the group receiving remdesivir versus 11.6% for the placebo group.'
'But the WHO-sponsored study said remdesivir and the other drugs just didn’t work.''The unpromising overall findings from the regimens tested suffice to refute early hopes, based on smaller or non-randomized studies, that any will substantially reduce inpatient mortality, initiation of ventilation or hospitalisation duration,” the study said.'"
https://www.webmd.com/lung/news/20201018/study-remdesivir-does-not-reduce-covid-mortality
